The results of an open-label extension study confirmed the interchangeability of biosimilar CT-917 with reference adalimumab for plaque psoriasis.

A real-world study finds elderly psoriasis patients treated with IL-17 and IL-23 inhibitors achieve comparable long-term ...

Healio spoke with Raj Chovatiya, MD, PhD, about results from the phase 3 ICONIC-LEAD trial presented at the 2025 Academy of ...

Living with psoriasis presents unique challenges, but with the right skincare routine, you can maintain healthy skin.

George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, "We are excited to share the results on this novel ...

Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia ...

Medically reviewed by Corinne Savides Happel, MD Allergies don't cause psoriasis, but you may be more likely to have ...

AROUND half a million Brits use weight loss drugs. And that number is expected to double in the next year with the rise in ...

Village Dermatology offers expert medical, surgical, and cosmetic skin care with same-day appointments in Houston & Katy.

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

For mild cases of traction alopecia, minoxidil may only need to be used for 12 months to fully restore the hairline. However, ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...